Applied Health Economics and Health Policy
Applied Health Economics and Health Policy is a journal indexed in SJR in Medicine (miscellaneous) and Economics and Econometrics with an H index of 56. It has a price of 3190 €. It has an SJR impact factor of 1,291 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,291.
Metrics
Scimago and CountryOfPapers database fields
SJR Impact
1,291
H-index
56
Docs (year)
80
Docs 3y
225
Total refs
4063
Cites 3y
812
Citable 3y
208
Cites/Doc 2y
3.55
Ref/Doc
50.79
Immediate OA
3190 €
Embargoed OA
NPD
Non OA / Submission
0 €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.
Researcher reviews
Best articles by citations
Community-based interventions to promote increased physical activity
View moreWhat is Required to Evaluate the Impact of Pharmaceutical Reference Pricing?
View moreDo Interventions to Increase Income Improve the Health of the Poor in Developed Economies and Are Such Policies Cost Effective?
View moreDisease-Specific Impoverishment Impact of Out-of-Pocket Payments for Health Care: Evidence from Rural Bangladesh
View moreDecentralisation Strategies and Provider Incentives in Healthcare
View moreCost-Effectiveness of Subsequent Whole-Brain Radiotherapy or Hippocampal-Avoidant Whole-Brain Radiotherapy Versus Stereotactic Radiosurgery or Surgery Alone for Treatment of Melanoma Brain Metastases
View moreCost-Effectiveness of Glycopyrronium Bromide Compared with Tiotropium in Patients with Chronic Obstructive Pulmonary Disease in Sweden
View moreCost-Effectiveness of a School-Based Social and Emotional Learning Intervention: Evidence from a Cluster-Randomised Controlled Trial of the Promoting Alternative Thinking Strategies Curriculum
View moreCost-Effectiveness Analysis: A View into the Abyss
View moreCost-Effectiveness Analysis of Early Treatment of Chronic HCV with Sofosbuvir/Velpatasvir in Italy
View moreCost Effectiveness of Human Papillomavirus-16/18 Genotyping in Cervical Cancer Screening
View moreComparing Utility Scores Before and After Hearing-Aid Provision
View moreComparing the Preferences of Health Professionals and Members of the Public for Setting Healthcare Priorities
View moreA Critical Systematic Review of Budget Impact Analyses on Drugs in the EU Countries
View moreClinical Practice Variation Needs to be Considered in Cost-Effectiveness Analyses: A Case Study of Patients with a Recent Transient Ischemic Attack or Minor Ischemic Stroke
View moreCan Privatising Selected Services Benefit the Public Healthcare System?
View moreCalculating Society???s Willingness to Pay for a QALY
View moreBarriers to the Equitable Funding of Primary Healthcare in South Africa
View moreAppropriateness' in Italy: A 'Magic Word' in Pharmaceuticals?
View moreAggregating Public Preferences for Healthcare
View moreAffordability of Medicines and Patients??? Cost-Reducing Behaviour
View moreA Wolf Dressed in Sheep???s Clothing
View moreA Tribute to the Life and Work of Bernie O???Brien
View moreA Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis
View more